Results 231 to 240 of about 1,232,742 (295)

Synthetic PS-III Glycoconjugate Vaccines Based on Solid-Phase Assembled Well-Defined Oligosaccharides Confers Protection against <i>Clostridium difficile</i>. [PDF]

ACS Cent Sci
Chen Y, Liu X, Zhang T, Wang Z, Li Y, Zeng J, Li H, Zong C, Liu Q.   +8 more
europepmc   +1 more source

Temporal trends in infectious risk among multiple myeloma patients treated with daratumumab: A meta‐analysis

British Journal of Haematology, EarlyView.
Summary Anti‐cluster of differentiation 38 (Anti‐CD38) monoclonal antibodies such as daratumumab are widely used in multiple myeloma (MM), yet the timing and magnitude of infectious risk remain incompletely defined. We performed an individual patient‐level meta‐analysis of six randomized trials (N = 2989) comparing daratumumab‐ versus non‐daratumumab ...
Alissa Visram, Hira Mian, James Lee, Aaron Jones, Gregory R. Pond, Doris Hansen, Surbhi Sidana, Luciano J. Costa   +7 more
wiley   +1 more source

Development of a cross-protective subunit cocktail vaccine against diverse serotypes of Glaesserella parasuis infection in pigs. [PDF]

Vet Res
Li F, Gong Y, Li Z, Wang Z, Wu Z, Zhang D, Zhang P, Lu Z, Chu H, Zhang K, Li D, Li N, Lei L.   +12 more
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

GMMA as adjuvant and carrier for mucosal delivery of group A streptococcus glycoconjugate vaccine. [PDF]

Hum Vaccin Immunother
Ozanne J, Saydam M, Palmieri E, Di Benedetto R, Aktar A, Carducci M, Rovetini L, Rossi O, Shaw HA, Micoli F, Mawas F.   +10 more
europepmc   +1 more source

Reverse vaccinology for development of vaccine against Aeromonas hydrophila infection in nile tilapia (Oreochromis niloticus). [PDF]

Braz J Microbiol
de Lima Carvalho GK, de Barros Cunha LS, de Brito MLE, da Silva Prado LC, de Castro Soares S, de Carvalho Azevedo VA, Brenig B, da Costa MM, de Simoni Gouveia JJ, Gouveia GV, Gouveia GV.   +10 more
europepmc   +1 more source

A Multi-Epitope FimH-CsgA-OmpA-Based Vaccine Induces Broad Anti-Adhesion Activity and Protects Chickens Against Avian Pathogenic <i>Escherichia coli</i> O2 Challenge. [PDF]

Life (Basel)
Cui J, Shao M, Wang L, Li G, Fang J, Ding Y, Gao W, Wai P, Feng Y, Pan Y, Zhou Y, Zhu C, Duan Q.   +12 more
europepmc   +1 more source

Construction and application of a novel respiratory syncytial virus vaccine based on <i>Bacteroides thetaiotaomicron</i> outer membrane vesicles. [PDF]

Front Microbiol
Li X, Li X, Jiang M, Hao Z, You Y, Xie Y, Zhang J, Du L, Xu Y, Li F, Zhao X.   +10 more
europepmc   +1 more source

Nanovaccination Against <i>Pseudomonas aeruginosa</i>: Immune Mechanisms, Antigen Design Strategies, and Nanocarrier Platforms. [PDF]

Int J Nanomedicine
Jin X, Li S, Liang S, Liu J, Fei F, Bian Q, Du X.   +6 more
europepmc   +1 more source

Serological correlates of disseminated <i>Borrelia burgdorferi</i> infection in mouse models of tick challenge. [PDF]

Microbiol Spectr
Freeman-Gallant G, Shrestha M, You S, Silva-Valenzuela CA, Carfi A, Finn MB, Dold C, Hu LT, Mantis N.   +8 more
europepmc   +1 more source